Sepracor - Journal Publications: OMNARIS® (ciclesonide) Nasal Spray


	About Sepracor	Products and Pipeline	News and Media	Therapeutic Areas

Products and Pipeline

XOPENEX^® (levalbuterol)

BROVANA^® (arformoterol)

OMNARIS^® (ciclesonide)

ALVESCO^® (ciclesonide)

LUNESTA^® (eszopiclone)

STEDESA^™ (eslicarbazepine acetate)

XOPENEX (levalbuterol) Publications

BROVANA (arformoterol) Publications

OMNARIS (ciclesonide) Publications

LUNESTA (eszopiclone) Publications

STEDESA (eslicarbazepine acetate) Publications

XOPENEX (levalbuterol) Abstracts

BROVANA (arformoterol) Abstracts

OMNARIS (ciclesonide) Abstracts

ALVESCO (ciclesonide) Abstracts

LUNESTA (eszopiclone) Abstracts

STEDESA (eslicarbazepine acetate) Abstracts

2009 OMNARIS (ciclesonide) Publications

1. Couroux P, Kunjibettu S, Hall N, Wingertzahn MA. Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology 2009;102:62-68.